Technical Description
This invention pertains to a nanoparticle-based composition designed for cancer treatment by inhibiting cell proliferation, angiogenesis, tumor growth, and anti-proliferative activity.
Problems Addressed
- Inefficient Drug Delivery
- Improper Cancer Management
- Nonspecific Targeted Delivery
- Expensive
- Systemic Cytotoxicity
- Poor Biocompatibility
Tech Features
- Lung Cancer Management
- Inhibits Cell Proliferation
- Sustained Drug release
- Specific Targeted Delivery
- No Cytotoxicity
- Prevents Burst Release of Composition
- Effective Absorption Capacity
- Cost-friendly
Target Audience
- Pharmaceutical Industry
- Oncology Clinics & Treatment Centres
- Nano Medicine & Drug Delivery Industry
- Research & Development
Tech ID: P06-1175 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
